000766 深市 通化金马

              通化金马药业集团股份有限公司

                  2024 年半年度财务报告

一、审计报告
半年度报告是否经过审计
□是  否
公司半年度财务报告未经审计。
二、财务报表
财务附注中报表的单位为：元
1、合并资产负债表
编制单位：通化金马药业集团股份有限公司

                                            2024 年 06 月 30 日

                                                                                                单位：元

              项目                            期末余额                          期初余额

 流动资产：

  货币资金                                            264,640,302.02                    177,445,962.68

  结算备付金

  拆出资金

  交易性金融资产                                          113,218.40                      1,048,549.60

  衍生金融资产

  应收票据                                              2,890,250.00                      5,290,611.85

  应收账款                                            497,419,598.81                    496,821,395.71

  应收款项融资                                        19,429,865.75                      18,198,766.80

  预付款项                                              8,715,841.89                      8,034,574.36
……